According to filings with the U.S. Securities and Exchange Commission, Catalyst OrthoScience is raising up to $5,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Carl Oconnell played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Catalyst OrthoScience
At Catalyst OrthoScience, our goal is to develop innovative medical solutions that make orthopedic surgery less invasive and more efficient for both surgeons and patients. Catalyst OrthoScience was founded by a board-certified orthopedic surgeon and is comprised of a team of biomedical industry professionals with more than 100 years of combined medical device experience. The Catalyst CSR Total Shoulder System is the result of the visionary insight of Steven Goldberg, M.D., a fellowship-trained orthopedic surgeon and shoulder specialist, who devised the next generation, higher precision, less-invasive total shoulder solution with a greatly simplified method of implant placement. The key design elements of this new system are 1) to preserve as much of the patients bone as possible, 2) to create implants to better mimic the natural elliptical shape of the human shoulder, and 3) to provide a system that greatly improves the consistency and reproducibility of the operation.

To learn more about Catalyst OrthoScience, visit http://www.catalystortho.com/

Contact:
Carl Oconnell, Chief Executive Officer
617-869-6255
https://www.linkedin.com/in/carl-o-connell/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.